Laboratory aspects of acute diseases surveillance and the needs for QA/QC

Size: px
Start display at page:

Download "Laboratory aspects of acute diseases surveillance and the needs for QA/QC"

Transcription

1 Laboratory aspects of acute diseases surveillance and the needs for QA/QC Kalashnikova T. ( DIH, EPO, CDC/CAR) Ongarbaev A. (Ref. Lab.Uzbekistan) Musabaev E. (Ref. Lab.Uzbekistan) Kuchuk T.(Ref. Lab. Kyrgyztan) Usmanov R. (Ref. Lab. Kyrgyztan) Mustafaeva E. (Ref. Lab.Uzbekistan) Kovtunenko N ( RL RC AIDS Kazazhstan) Jumagulova A. (DIH, EPO, CDC/CAR) Suleymenova S.(Ref. Lab Kazazhstan) Drobeniuk J. (DVH, NCID, CDC) Golovchenko N.I.(RL RC AIDS Kyrgyzstan) Favorov M. (DIH, EPO, CDC/CAR)

2 The Quality Assurance Cycle Reporting Patient/Client Prep Sample Collection Data and Lab Management Safety Customer Service Personnel Competency Test Evaluations Sample Receipt and Accessioning Record Keeping Quality Control Testing Sample Transport 2

3 Features of laboratory service in Central Asia region Absence of continuously postgraduate education for laboratory specialists Short supply with technical facilities Absence of laboratory control of test kits Absence of steady monitoring for analysis quality in every single laboratory (IQCl) and state (EQC) 3

4 GOAL Establishing and implementation of laboratorial quality assurance system for HIV and viral hepatitis diagnosing in states of Central Asia 4

5 OBJECTIVES Training of Central Asia specialist of rules of quality assurance and quality control (QA/QC) Establishing national referencelaboratories (NRL) for implementation of basis of QA Internal Quality Control and program of External Quality Control 3. Creation of background for further development of QA through integration of NRL to present laboratory service system 5

6 TRAINING 18 QA and HIV and hepatitis laboratory diagnostics training courses were held in different regions of Central Asia: Kyrgyzstan (1998, 2002, 2003) Uzbekistan (1999, 2000, 2001, 2002, 2003(2),2004) Kazakhstan (2000, 2001, 2002(2), 2003(2) Turkmenia (2000,2004) 438 of participants representatives of laboratory service system from several regions of republics Blood Donor Centers Infectious diseases hospitals Private laboratories SSC (sanitarian surveillance centers) Lecturing in quality control have been included to workshops for epidemiologists and practitioners in Central Asia 6

7 Distribution of participants with over 70% of successful examination rate Before training After training Uzbekistan-2000 Uzbekistan-1999 Kirgizia-1998 Uzbekistan-2001(HV) Kazakhstan-2001(HV) Kazakhstan-2000(HV) Turkmenia-2000(HV) Uzbekistan (HIV) Kirgizia (QAT HIV) Uzbekistan-2001 (HIV) Kazakhstan-2000 (HIV) Kazakhstan-2001 (HV) Kirgizia (QAT HIV) 7

8 16.00 Res ults of laboratorial day of quality control works hop in Tashkent (June 2002) Reference (V-0,3-1,7) Group 1 (V=3,2-5,6) Group 2 (V=16,0-35,8) Group 3 (V=6,8-10,6) Group 4 (V=4,2-4,3)

9 Reference laboratories for HIV and viral hepatitis were established in four states of Central Asia Kyrgyzstan ( 1998) Uzbekistan*( 1999) Kazakhstan ( 2000) Turkmenistan ( 2000) * Joint project with Swiss agency of emergent events and CDC/USAID 9

10 JURAL BASIS OF NRL The principals of establishing of assurance of quality control system are fixed in «Regulation of activity of reference laboratories» and approved by Ministry of Health 10

11 Implementation QA program in acute viral hepatitis sentinel surveillance in Kyrgyzstan 11

12 Organizational Scheme of preanalytical step of the research Obl. hospital for children, Naryn Lab Obl. hospital for adults, Naryn City SES, Bishkek RL Obl. Hospital for children, Zhalal- Abad Lab Lab Obl. Hospital for adults, Zhalal- Abad Hospital for infectious diseases, Bishkek 12

13 Quality Performance of test-system system on HBsAg ( 2000 ) SHORT NAME OF THE TEST- SYSTEMS HBs антиген-ифа» Sensitivity Sample Correlation 31/31 % 100 Specificity Sample Correlation 0/37 % 0 «Рекоматгеп В- стрип» 23/31 74,1 49/50 98 Вектогеп В- HBsAg-стрип» 25/31 80,6 50/ «Рекоматгеп В- стрип» 31/ /50 66 «ИФА-HBsAg/м» 30/ / HBsAg-ИФА 22/31 70,9 50/

14 The evaluation of the quality assurance systems effectiveness for the laboratory researches in Sentinel Epidemiologic Surveillance of Kyrgyzia was conducted by repeated research of 25% of the samples in the reference- laboratory for virus hepatitis diagnosis in CDC Atlanta 14

15 Results of data comparison from RL of Kyrgyzia and RL of CDC Atlanta ( 2002 ) Marker anti-вга IgM Presence of the marker positive negative CDC Data Number of correct RL data Number of errors 3 15 total ( 3,0%) 15

16 Results of data comparison from RL of Kyrgyzia and RL of CDC Atlanta ( 2002 ) Marker Anti-HCV Presence of the marker positive CDC Data 59 Number of correct 46 RL data Number of errors 13 negative total ( 3,8%) 16

17 Results of data comparison from RL of Kyrgyzia and RL of CDC Atlanta ( 2002 ) Marker anti- HBcor IgM Presence of the marker positive negative CDC Data Number of correct RL data Number of errors 34 7 total ( 9,8%) 17

18 Results of data comparison from RL of Kyrgyzia and RL of CDC Atlanta ( 2002 ) Marker HBsAg Presence of the marker positive CDC Data 243 Number of correct 172 RL data Number of errors 71 negative total ( 12,7%) 18

19 EQC Results of 19 laboratories of AIDS Centers of Kazakhstan ( 2002 ) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% negative HBsAg 5 ng/ml. HBsAg 1 ng/ml HBsAg 0,25 ng/ml negative High positive Weak positive negative High positive Midlle positive Weak positive HBsAg Anti-HCV Anti-HIV 19

20 Conclusion (1) The program of quality assurance of laboratory diagnosing of HIV and viral hepatitis has been developed and implemented in Uzbekistan, Kazakhstan and Kyrgyzstan The realization of program allowed: Training the rules of quality assurance to laboratory experts of Central Asia Obtaining the objective results of monitoring of viral hepatitis in Kyrgyzstan Organization of quality control of test kits while licensing and further production in Uzbekistan and Kirhizia Monitor the quality of testing of HBsAg, anti-hcv, anti-hiv while EQC in Uzbekistan, Kazakhstan and Kyrgyzstan 20

21 Conclusion (2) The QA will be improved by: Implementation of the national External Quality Control programs on the regular basis (Kazakhstan, Uzbekistan) Realization of the interregional EQC programs (NRL of AIDS Centers of Kazakhstan and Kyrgyzstan, 2003) Participation in the international EQC programs МPEP, Atlanta CDC, 2004 (Kazakhstan 6: Uzbekistan-10: Kyrgyzia -1) PTP anti-hiv DBS, CDC Atlanta, 2004 (Kazakhstan -6 lab, Uzbekistan -1 lab, Kyrgyzia- 1 lab 21

22 Thank you for your attention 22

Integrating Surveillance - Essential Constituent for HIV/AIDS, Viral Hepatitis, and STDs Control and Prevention

Integrating Surveillance - Essential Constituent for HIV/AIDS, Viral Hepatitis, and STDs Control and Prevention Integrating Surveillance - Essential Constituent for HIV/AIDS, Viral Hepatitis, and STDs Control and Prevention Michael Favorov MD, Ph.D., D.Sc., Harold Margolis MD, CDC Central Asia Program, DIH, EPO;

More information

Vol. 5, No. 20 Fall 2010

Vol. 5, No. 20 Fall 2010 Vol. 5, No. 20 Fall 2010 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in Review

More information

Vol. 6, No. 21 Winter

Vol. 6, No. 21 Winter Vol. 6, No. 21 Winter 2010-2011 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in

More information

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings Elizabeth M. Dax with the staff of the National Serology Reference Laboratory, Australia My Background Worked in HIV

More information

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010 Report of the 16 th Core Group meeting Almaty, Kazakhstan May 26-28, 2010 The 16 th meeting of the Core Group of the TB/HIV Working Group of the Stop TB Partnership was conducted in Almaty, Kazakstan from

More information

Vol. 5, No. 18 Spring 2010

Vol. 5, No. 18 Spring 2010 Vol. 5, No. 18 Spring 2010 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in Review

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

PUBLIC ASSOCIATION OF PARENTS OF CHILDREN WITH AUTISM HAND IN HAND, KYRGYZSTAN.

PUBLIC ASSOCIATION OF PARENTS OF CHILDREN WITH AUTISM HAND IN HAND, KYRGYZSTAN. PUBLIC ASSOCIATION OF PARENTS OF CHILDREN WITH AUTISM HAND IN HAND, KYRGYZSTAN. Our History Public Association of parents of children with autism, "Hand in Hand" was organized in June 2012 by a group of

More information

Structure and duties of Blood service

Structure and duties of Blood service NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,

More information

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies 2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1

More information

TB/HIV Project in the Philippines. Yumiko Yanase

TB/HIV Project in the Philippines. Yumiko Yanase TB/HIV Project in the Philippines Yumiko Yanase 1 TB situation in the Philippines Global rank: 9th Incidence (all): 296 Prevalence (all): 458 TB mortality (all): 49 New MDR-TB: 3.2% Case types notified

More information

Appendix 11 Roles and Responsibilities October, 2013 Page 1 of 5

Appendix 11 Roles and Responsibilities October, 2013 Page 1 of 5 October, 2013 Page 1 of 5 Exposed Person To present to a health care facility as soon as possible following the exposure (ideally within 2 hours). To answer assessment questions. (Refer to Appendix 15

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Adequate and Appropriate Donor Screening Tests for Hepatitis B; Hepatitis B Surface Antigen (HBsAg) Assays Used to Test Donors of Whole Blood and Blood Components, Including Source

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately

More information

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public

More information

Plasma for fractionation: South African Plasma Requirements

Plasma for fractionation: South African Plasma Requirements Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal

More information

The Laboratories Role in Global Health

The Laboratories Role in Global Health The Laboratories Role in Global Health Larry Westerman, Ph.D. International Laboratory Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention Center for Global Health International

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hepatitis A Revised March 2017 Hepatitis A 1.0 Provincial Reporting

More information

WHO Prequalification of In Vitro Diagnostics Programme

WHO Prequalification of In Vitro Diagnostics Programme WHO Prequalification of In Vitro Diagnostics Programme International HIV/Viral Hepatitis Co-Infection Satellite Meeting 19 July 2014, Melbourne Anita Sands Prequalification Diagnostics Team Department

More information

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic

More information

Name of the presenter

Name of the presenter Progress in tuberculosis care: setting the scene for Central Asia Name of the presenter Gombogaram Tsogt, Shalva Gamtsemlidze Quality Health Care Project Global TB estimates All forms of TB greatest number

More information

Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia

Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia Background HIV incidence continues to rise in Central Asia and Eastern Europe. Between 2010 and 2015, there

More information

HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia

HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia Nikoloz Chkhartishvili, MD, MS, PhD Deputy Executive Director for Research Infectious Diseases, AIDS and Clinical Immunology

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 5 PURPOSE To provide guidelines on the treatment and care of patients with Hepatitis. POLICY Hepatitis is an injury to hepatic cells and an inflammatory process in the liver. The major causes

More information

OIE Collaborating Centers Reports Activities

OIE Collaborating Centers Reports Activities OIE Collaborating Centers Reports Activities Activities in 2014 This report has been submitted : 2015-04-24 16:02:49 Title of collaborating centre: Emerging and Re-Emerging Zoonotic Diseases Address of

More information

HIV Drug Resistance (HIVDR)

HIV Drug Resistance (HIVDR) Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,

More information

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management

More information

Technical guidance for Round 9 Global Fund HIV proposals

Technical guidance for Round 9 Global Fund HIV proposals Technical guidance for Round 9 Global Fund HIV proposals Broad Area Service Delivery Area TREATMENT Prevention and assessment of HIV drug resistance (HIVDR) This technical brief provides key information

More information

Epidemiology of blood-borne Infections in Vietnam

Epidemiology of blood-borne Infections in Vietnam IPFA 4 th Asia Workshop on Plasma Quality and Supply Epidemiology of blood-borne Infections in Vietnam Nguyen Thị Lan Anh MD, PhD Center for Bio-Medical Rsearch Screening donated blood for infections:

More information

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1 The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,

More information

QSEAL Recovered Plasma Specification

QSEAL Recovered Plasma Specification QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards

More information

Viral Hepatitis in Blood Donors

Viral Hepatitis in Blood Donors Viral Hepatitis in Blood Donors VHPB country meeting Prof Asc.Vjollca Durro Microbiology Service Medicine Faculty, Medical University Tirana, 27-28 OCTOBER 2016 1 Transfusion-transmitted viral infections

More information

Technical Guidance Note for Round 11 Global Fund HIV Proposals

Technical Guidance Note for Round 11 Global Fund HIV Proposals Technical Guidance Note for Round 11 Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including HIVDR prevention and assessment in the proposal Situation analysis As access

More information

The Hepatitis B-e antigen-positive

The Hepatitis B-e antigen-positive The Hepatitis B-e antigen-positive Dental Student Developing an Equitable Policy Hepatitis B Virus Serology 1 HBsAg A protein on the surface of HBV; it can be detected in high levels in serum during acute

More information

Ministry of Health Kyrgyz Republic. National Center Cardiology and Internal Medicine. GARD in Kyrgyzstan. Talant M. Sooronbaev.

Ministry of Health Kyrgyz Republic. National Center Cardiology and Internal Medicine. GARD in Kyrgyzstan. Talant M. Sooronbaev. Ministry of Health Kyrgyz Republic National Center Cardiology and Internal Medicine GARD in Kyrgyzstan Talant M. Sooronbaev Istambul, 2008 KYRGYZ REPUBLIC 90% of its territory is covered by mountains the

More information

Examples COMPLETED. Immunization Forms

Examples COMPLETED. Immunization Forms Important Notes: Examples of COMPLETED Immunization Forms - The form MUST be completed, signed and dated by the physician. - The form MUST also be signed and dated by the student. - Chest X-rays should

More information

Negative Hepatitis C Reporting and Linkage to Care Outreach

Negative Hepatitis C Reporting and Linkage to Care Outreach Negative Hepatitis C Reporting and Linkage to Care Outreach NASTAD 7 th National Hepatitis Technical Assistance Meeting November 28-30, 2017 Angelica Bocour, MPH Director of Viral Hepatitis Surveillance

More information

INSTITUTO DE SALUD CARLOS III (ISCIII)

INSTITUTO DE SALUD CARLOS III (ISCIII) Instituto de Salud Carlos III 1 INSTITUTO DE SALUD CARLOS III (ISCIII) Institute of Health Carlos III ISCIII is a scientific support organisation to the National Health System, a public research centre

More information

Vol. 6, No. 23 Summer 2011

Vol. 6, No. 23 Summer 2011 Vol. 6, No. 23 Summer 2011 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in Review

More information

Overview of Influenza Surveillance in Korea

Overview of Influenza Surveillance in Korea Overview of Influenza Surveillance in Korea SUNHEE PARK Korea Centers for Diseases Control & Prevention 1 contents I. II. III. Introduction Influenza Surveillance System Use of Surveillance Data 2 General

More information

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and

More information

Influenza Surveillance Report

Influenza Surveillance Report Influenza Surveillance Report www.infectiousdisease.dhh.la.gov Week 5: 12/23/18-12/29/18 Influenza activity increased this week in Louisiana. Rhino/Enteroviruses, RSV, and Coronaviruses represent the majority

More information

INTERPRETING HEPATITIS B SEROLOGY

INTERPRETING HEPATITIS B SEROLOGY INTERPRETING HEPATITIS B SEROLOGY RECOMMENDED WORDING FOR NATIONAL LABORATORIES TO REPORT HEPATITIS B DIAGNOSTIC TEST RESULTS THIS DOCUMENT HAS BEEN ENDORSED BY: Australasian Society for HIV Medicine,

More information

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting Different Aspects of Viral Hepatitis Health Care Workers and Viral Hepatitis in Turkey Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting 12 13 November 2009 Istanbul. Turkey Hepatitis B and

More information

Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies. Willy Urassa. AMD STAKE HOLDERS MEETING 7-8 May 2013

Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies. Willy Urassa. AMD STAKE HOLDERS MEETING 7-8 May 2013 Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies Willy Urassa 1 Outline Definition Introduction Vision Broad strategies Progress so far Recent experience 2 Expansion of

More information

EXPOSURE (HIV/HEPATITIS) BLOOD & BODY FLUIDS

EXPOSURE (HIV/HEPATITIS) BLOOD & BODY FLUIDS Page(s): 1 of 11 PURPOSE To set a standardized procedure to ensure that employees are evaluated in a consistent and timely manner.. POLICY A. The treatment of Team Member exposure to bloodborne pathogens

More information

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. The State of Cardiovascular Disease in the Kyrgyz Republic Ryskul B. Kydyralieva The National Center of Cardiology and Internal Medicine named after academician M.Mirrahimov at Ministry of Health of the

More information

DAT-B 2015 Direct Antiglobulin Test

DAT-B 2015 Direct Antiglobulin Test EVALUATION DAT-B 2015 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 28002258 10/12/2015 11/16/2015 Next Mailing Date: 2/22/2016 COPIED TO: LAP

More information

QUALITY CONTROL Infectious Disease

QUALITY CONTROL Infectious Disease QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).

More information

Kyrgyz Republic: Tobacco Facts. Source: Richard Peto etc Mortality from smoking in developed countries,

Kyrgyz Republic: Tobacco Facts. Source: Richard Peto etc Mortality from smoking in developed countries, Kyrgyz Republic: Tobacco Facts 1. Tobacco is one of only two major causes of death worldwide that are still increasing: the other is infection with human immunodeficiency virus HIV-AIDS. At current smoking

More information

Anti-Infective Clinical Trials

Anti-Infective Clinical Trials Anti-Infective Clinical Trials The extensive clinical training and experience of our infectious disease staff places us in a unique position to fully appreciate the requirements of our clients conducting

More information

Update: ACIP Recommendations for Hepatitis B Vaccination

Update: ACIP Recommendations for Hepatitis B Vaccination National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Update: ACIP Recommendations for Hepatitis B Vaccination Sarah Schillie, MD, MPH, MBA Summit for the Elimination of Hepatitis B and

More information

An Evaluatio ti n o of the Accura Accur cy y of Patient Data in Patien NEDSS 10/

An Evaluatio ti n o of the Accura Accur cy y of Patient Data in Patien NEDSS 10/ An Evaluation of the Accuracy of Patient Data in NEDSS 10/23/2010 Andrea E. Palmer Graduate Research Assistant Center for TB Control and Prevention Maryland Department of Health and Mental Hygiene Infectious

More information

Port Gamble S'Klallam Tribe POLICIES/PROCEDURES. Employee Immunity Assessment and Immunization Policy

Port Gamble S'Klallam Tribe POLICIES/PROCEDURES. Employee Immunity Assessment and Immunization Policy Port Gamble S'Klallam Tribe POLICIES/PROCEDURES Employee Immunity Assessment and Immunization Policy Applies To: All Employees subject to the PGST Employee Handbook Purpose The purpose of this policy is

More information

Using Surveillance Data for Linkage to Care in Baltimore City, Maryland NASTAD Technical Assistance Meeting November 29, 2017

Using Surveillance Data for Linkage to Care in Baltimore City, Maryland NASTAD Technical Assistance Meeting November 29, 2017 Using Surveillance Data for Linkage to Care in Baltimore City, Maryland NASTAD Technical Assistance Meeting November 29, 2017 Brionna Hair, PhD, MPH Epidemiologist Office of Epidemiology Services/Acute

More information

1 st International Reference Panel for HIV-1 RNA Genotypes NIBSC code: 01/466

1 st International Reference Panel for HIV-1 RNA Genotypes NIBSC code: 01/466 1 st International Reference Panel for HIV-1 RNA Genotypes NIBSC code: 01/466 Instructions for Use (8 th September 2004, Version 3) Changes from previous version are highlighted in red, deletions are shown

More information

Influenza Situation Update 11 November 2014 http://www.wpro.who.int/emerging_diseases/influenza/en/index.html Influenza surveillance summary This influenza surveillance summary includes countries where

More information

The impact of Global Fund transition strategies on national HIV programs in Central Asia.

The impact of Global Fund transition strategies on national HIV programs in Central Asia. The impact of Global Fund transition strategies on national HIV programs in Central Asia. Anna Deryabina, MD, MScIH, DrPH Director for Central Asia ICAP at Columbia University July 26, 2018 Introduction

More information

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience 2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October

More information

Kyrgyzstan. Medicine prices, availability, affordability & price components

Kyrgyzstan. Medicine prices, availability, affordability & price components Kyrgyzstan Medicine prices, availability, affordability & price components Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially

More information

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia

More information

Hepatitis Update. Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases

Hepatitis Update. Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases Hepatitis Update Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases Division of Disease Control and Health Protection To protect, promote and improve the

More information

Viral Hepatitis B and C in North African Countries

Viral Hepatitis B and C in North African Countries Viral Hepatitis B and C in North African Countries Prevalence, Risk factors and How to prevent Prof. Ossama Rasslan President, ESIC ICAN, Vice-Chair ICAN 2014, Harare, Zimbabwe, Nov 3rd 5th Overview Viral

More information

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group Targeting HIV Settings Through PEPFAR Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group PEPFAR Laboratory Program is a Critical part of Health Systems Strengthening Mission: To support countries

More information

Outcome of meeting of the National Influenza Centers (NICs) in the Asia-Pacific Region. WHO Regional Office for South East Asia New Delhi

Outcome of meeting of the National Influenza Centers (NICs) in the Asia-Pacific Region. WHO Regional Office for South East Asia New Delhi Outcome of meeting of the National Influenza Centers (NICs) in the Asia-Pacific Region WHO Regional Office for South East Asia New Delhi Background 10th Bi-Regional Meeting of National Influenza Centers

More information

Prioritizing Emergency Polio Eradication Activities

Prioritizing Emergency Polio Eradication Activities Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b

More information

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis

More information

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013 Hepatitis B and C Overview, Outbreaks, and Recommendations Elizabeth Lawlor, MS Healthy Kansans living in safe and sustainable environments. Viral Hepatitis Language Acute infection is when the infection

More information

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium

More information

WEST EURASIA FMD LAB PHASE ACTIVITY PROPOSAL. A. Naci BULUT Head of the Diagnosis Department, Şap Institute

WEST EURASIA FMD LAB PHASE ACTIVITY PROPOSAL. A. Naci BULUT Head of the Diagnosis Department, Şap Institute WEST EURASIA FMD LAB NETWORK WELNET FMD- 2ND PHASE ACTIVITY PROPOSAL FAO/the EuFMD Commission, 39th General Session, 27/28 April 2011 Rome, Italy A. Naci BULUT Head of the Diagnosis Department, Şap Institute

More information

Understanding Quality Control for Infectious Disease Testing. Wayne Dimech ASLM Quality Control Workshop Abuja, Nigeria 9 th December 2018

Understanding Quality Control for Infectious Disease Testing. Wayne Dimech ASLM Quality Control Workshop Abuja, Nigeria 9 th December 2018 Understanding Quality Control for Infectious Disease Testing Wayne Dimech ASLM Quality Control Workshop Abuja, Nigeria 9 th December 2018 Disclosure Attendance at ASLM part-sponsored by CDC No personal

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10% % of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),

More information

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized

More information

Undergraduate Medical Education

Undergraduate Medical Education Undergraduate Medical Education Communicable Disease Screening Protocol Student Conduct Component: Procedure #SC 08P Corresponding Policy: Policy #SC-08 Supersedes: none Lead Writer: Communicable Disease

More information

An Introduction to Access to Diagnostics. 14:00-14:45 BST 17 June

An Introduction to Access to Diagnostics. 14:00-14:45 BST 17 June An Introduction to Access to Diagnostics 14:00-14:45 BST 17 June Chair: Dr Greg Martin, Specialist Registrar, Public Health Medicine and Editor-in- Chief of Globalization and Health @drgregmartin Speakers:

More information

3/23/2016. Managing Bloodborne Pathogen Exposures. Managing Bloodborne Pathogen Exposures

3/23/2016. Managing Bloodborne Pathogen Exposures. Managing Bloodborne Pathogen Exposures This webinar begins at 11 a.m., Eastern. You will not hear anything over your telephone line until the program starts. If the system did not prompt you to enter your phone number and receive a call back,

More information

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution

More information

IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges

IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges Ahmed Meghzifene Head, Dosimetry & Medical Radiation Physics Presentation objectives To learn about: 1. IAEA activities

More information

Influenza Report Week 03

Influenza Report Week 03 2015-2016 Influenza Report Week 03 January 17 January 23, 2016 About our flu activity reporting MSDH relies upon selected sentinel health practitioners across the state to report the percentage of total

More information

Influenza Situation Update 14 October 2014 http://www.wpro.who.int/emerging_diseases/influenza/en/index.html Influenza surveillance summary This surveillance summary includes countries where routine surveillance

More information

Kazakhstan. offers ample evidence (1) that following a period of quick success in the control of goiter and cretinism

Kazakhstan. offers ample evidence (1) that following a period of quick success in the control of goiter and cretinism Kazakhstan Prior to Independence in 1991, Kazakhstan was a Republic of the USSR. The Soviet historical record offers ample evidence (1) that following a period of quick success in the control of goiter

More information

The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group

The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group 5 th meeting of the GF TADs Regional Steering Committee for Europe October 8 th -9th

More information

Issue No. 6, December 2012

Issue No. 6, December 2012 Issue No. 6, December 2012 From the WHO Regional Office for Europe, WHO/Europe http://www.euro.who.int/ Flu Focus is an e-magazine published by the WHO Regional Office for Europe that covers recent developments,

More information

NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens

NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens Vincini GA*, Cabuang LM, Land S, Best SJ NRL London, 12 January 2011 NRL EQAS for NAT HCV Genotyping

More information

COFM Immunization Policy 2016

COFM Immunization Policy 2016 COFM Immunization Policy 2016 Council of Ontario Faculties of Medicine June 2016 COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities COFM Immunization Policy 2016

More information

Ñëàéäû èíæåíåðíîé ñëóæáû àñòü 2.pptx. Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor), FGBI «ARRIAH» 1

Ñëàéäû èíæåíåðíîé ñëóæáû àñòü 2.pptx. Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor), FGBI «ARRIAH» 1 Ñëàéäû èíæåíåðíîé ñëóæáû àñòü 2.pptx 1 FGBI «ARRIAH» 2 Number of FMD outbreaks in the USSR in 1961-1976 Annual losses > $ 10 mln 3 1958 - All-Union Research Foot and Mouth Disease Institute Number of FMD

More information

Progress Toward Quality Management Systems Implementation and Laboratory Accreditation in the Caribbean region

Progress Toward Quality Management Systems Implementation and Laboratory Accreditation in the Caribbean region Progress Toward Quality Management Systems Implementation and Laboratory Accreditation in the Caribbean region George Alemnji, Ph.D. Laboratory Advisor, Global AIDS Program CDC Caribbean Regional Office

More information

PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases

PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission

More information

H1N1 Disease & Vaccine in Maryland

H1N1 Disease & Vaccine in Maryland H1N1 Disease & Vaccine in Maryland A Webcast for Registered Vaccine Providers October 22, 2009 E-mail Questions to: maphtc@jhsph.edu 1 Program & Panel Presenters Introductory Remarks:- John M. Colmers,

More information

The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective

The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective National Center for Immunization & Respiratory Diseases The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective Nancy Fenlon, RN, MS Perinatal Hepatitis B Prevention Program Coordinator,

More information

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Head of Delegation HERAWATI SUDOYO MD, PHD Eijkman Institute for Molecular Biology Ministry for Research and Technology

More information

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia 1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples

More information

Kingdom of. Bahrain FOR

Kingdom of. Bahrain FOR Kingdom of Bahrain Ministry of Health Public Health Directorate Diseases Control Section POLICY FOR IMMUNIZATION AND INFECTIOUS DISEASES SCREENING FOR MEDICAL, DENTAL, NURSING, AND PHYSIOTHERAPY STUDENTS

More information

Development and producing National HIV- Seroconversional Panels on the basis of Institute of Immunology, Uzbek Academy of Sciences

Development and producing National HIV- Seroconversional Panels on the basis of Institute of Immunology, Uzbek Academy of Sciences Development and producing National HIV- Seroconversional Panels on the basis of Institute of Immunology, Uzbek Academy of Sciences Organization Applicant: Institute of Immunology, Academy of Science of

More information

HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS

HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS VIRAL HEPATITIS PREVENTION BOARD MEETING LISBON, PORTUGAL, 18 19 November 2010 Gabriel de Olim Presidente do Conselho Directivo do Instituto Português

More information

Mom Chandara, Msc, NIPH Team

Mom Chandara, Msc, NIPH Team Mom Chandara, Msc, NIPH Team EXTERNAL QUALITY ASSESSMENTS (EQAS) EQA refers to a system in which laboratory results are scrutinized objectively by an outside agency in order to get a general impression

More information